Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Riociguat by Bayer for Sickle Cell Disease: Likelihood of Approval
Riociguat is under clinical development by Bayer and currently in Phase II for Sickle Cell Disease. According to GlobalData, Phase...